Health Sciences Acquisitions Corporation (NASDAQ:HSAC) saw unusually-strong trading volume on Wednesday following insider buying activity. Approximately 1,088,100 shares traded hands during mid-day trading, an increase of 931% from the previous session’s volume of 105,531 shares.The stock last traded at $10.16 and had previously closed at $10.14.
Specifically, CEO Roderick Wong sold 2,000 shares of Health Sciences Acquisitions stock in a transaction on Monday, November 11th. The shares were sold at an average price of $36.52, for a total value of $73,040.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders acquired 167,528 shares of company stock valued at $1,712,448 in the last ninety days.
An institutional investor recently bought a new position in Health Sciences Acquisitions stock. K2 Principal Fund L.P. bought a new stake in Health Sciences Acquisitions Corporation (NASDAQ:HSAC) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 102,926 shares of the company’s stock, valued at approximately $1,008,000.
Health Sciences Acquisitions Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the healthcare and healthcare-related industries in North America or Europe.
Further Reading: Trade Deficit
Receive News & Ratings for Health Sciences Acquisitions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Sciences Acquisitions and related companies with MarketBeat.com's FREE daily email newsletter.